USANA Health Sciences ROE 2012-2026 | USNA

Current and historical return on equity (ROE) values for USANA Health Sciences (USNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2026-03-31 $0.01B $0.53B 1.69%
2025-12-31 $0.01B $0.53B 1.89%
2025-09-30 $0.02B $0.53B 3.02%
2025-06-30 $0.03B $0.53B 6.40%
2025-03-31 $0.03B $0.53B 6.45%
2024-12-31 $0.04B $0.52B 8.09%
2024-09-30 $0.06B $0.51B 10.77%
2024-06-30 $0.06B $0.50B 11.12%
2024-03-31 $0.06B $0.48B 12.81%
2023-12-31 $0.06B $0.47B 13.33%
2023-09-30 $0.06B $0.46B 12.91%
2023-06-30 $0.06B $0.44B 14.25%
2023-03-31 $0.07B $0.43B 15.26%
2022-12-31 $0.07B $0.41B 16.84%
2022-09-30 $0.08B $0.40B 19.00%
2022-06-30 $0.09B $0.40B 22.17%
2022-03-31 $0.11B $0.40B 26.70%
2021-12-31 $0.12B $0.40B 28.71%
2021-09-30 $0.14B $0.42B 32.71%
2021-06-30 $0.14B $0.41B 33.88%
2021-03-31 $0.13B $0.40B 32.85%
2020-12-31 $0.13B $0.38B 33.64%
2020-09-30 $0.12B $0.35B 33.24%
2020-06-30 $0.11B $0.33B 33.01%
2020-03-31 $0.10B $0.34B 30.12%
2019-12-31 $0.10B $0.36B 27.76%
2019-09-30 $0.10B $0.37B 27.30%
2019-06-30 $0.11B $0.40B 26.97%
2019-03-31 $0.12B $0.41B 29.39%
2018-12-31 $0.13B $0.41B 30.42%
2018-09-30 $0.09B $0.41B 21.61%
2018-06-30 $0.08B $0.39B 20.82%
2018-03-31 $0.07B $0.38B 18.54%
2017-12-31 $0.06B $0.37B 16.95%
2017-09-30 $0.09B $0.36B 25.26%
2017-06-30 $0.10B $0.34B 28.03%
2017-03-31 $0.10B $0.32B 31.40%
2016-12-31 $0.10B $0.29B 34.72%
2016-09-30 $0.10B $0.28B 36.82%
2016-06-30 $0.10B $0.28B 35.22%
2016-03-31 $0.10B $0.28B 34.52%
2015-12-31 $0.10B $0.28B 33.57%
2015-09-30 $0.09B $0.27B 34.04%
2015-06-30 $0.09B $0.24B 35.16%
2015-03-31 $0.08B $0.23B 33.76%
2014-12-31 $0.08B $0.24B 31.57%
2014-09-30 $0.08B $0.25B 30.18%
2014-06-30 $0.07B $0.26B 28.24%
2014-03-31 $0.08B $0.25B 31.39%
2013-12-31 $0.08B $0.23B 35.03%
2013-09-30 $0.08B $0.21B 37.24%
2013-06-30 $0.08B $0.20B 39.24%
2013-03-31 $0.07B $0.19B 37.09%
2012-12-31 $0.07B $0.19B 34.83%
2012-09-30 $0.06B $0.19B 32.71%
2012-06-30 $0.06B $0.18B 31.64%
2012-03-31 $0.05B $0.17B 31.45%
2011-12-31 $0.05B $0.16B 31.50%
2011-09-30 $0.05B $0.15B 32.24%
2011-06-30 $0.05B $0.15B 34.54%
2011-03-31 $0.05B $0.13B 35.61%
2010-12-31 $0.05B $0.12B 39.83%
2010-09-30 $0.04B $0.10B 45.24%
2010-06-30 $0.04B $0.08B 48.45%
2010-03-31 $0.04B $0.07B 53.62%
2009-12-31 $0.03B $0.06B 58.87%
2009-09-30 $0.03B $0.05B 59.26%
2009-06-30 $0.03B $0.04B 66.27%
2009-03-31 $0.03B $0.04B 65.54%
2008-12-31 $0.03B $0.05B 62.37%
2008-09-30 $0.04B $0.05B 77.01%
2008-06-30 $0.04B $0.04B 92.31%
2008-03-31 $0.04B $0.03B 128.00%
2007-12-31 $0.05B $0.04B 122.45%
2007-09-30 $0.04B $0.04B 101.15%
2007-06-30 $0.04B $0.05B 85.57%
2007-03-31 $0.04B $0.06B 75.34%
2006-12-31 $0.04B $0.05B 76.92%
2006-09-30 $0.04B $0.05B 82.47%
2006-06-30 $0.04B $0.05B 76.56%
2006-03-31 $0.04B $0.06B 71.11%
2005-12-31 $0.04B $0.06B 68.42%
2005-09-30 $0.04B $0.06B 66.09%
2005-06-30 $0.04B $0.05B 68.25%
2005-03-31 $0.03B $0.05B 65.67%
2004-12-31 $0.03B $0.05B 65.22%
2004-09-30 $0.03B $0.05B 62.22%
2004-06-30 $0.03B $0.04B 63.41%
2004-03-31 $0.02B $0.04B 61.33%
2003-12-31 $0.02B $0.03B 64.12%
2003-09-30 $0.02B $0.03B 64.76%
2003-06-30 $0.01B $0.02B 57.78%
2003-03-31 $0.01B $0.02B 57.89%
2002-12-31 $0.01B $0.02B 47.06%
2002-09-30 $0.01B $0.02B 36.92%
2002-06-30 $0.01B $0.02B 32.26%
2002-03-31 $0.00B $0.02B 20.34%
2001-12-31 $0.00B $0.01B 14.29%
2001-09-30 $0.00B $0.01B 14.81%
2001-06-30 $0.00B $0.01B 7.69%
2001-03-31 $0.00B $0.01B 8.00%
2000-12-31 $0.00B $0.01B 16.33%
2000-09-30 $0.00B $0.01B 24.49%
2000-06-30 $0.00B $0.01B 16.67%
2000-03-31 $0.00B $0.02B 23.88%
1999-12-31 $0.01B $0.02B 22.73%
1999-09-30 $0.01B $0.03B 22.64%
1999-06-30 $0.01B $0.03B 32.79%
1999-03-31 $0.01B $0.03B 34.78%
1998-12-31 $0.01B $0.03B 38.83%
1998-09-30 $0.01B $0.02B 39.56%
1998-06-30 $0.01B $0.02B 39.51%
1998-03-31 $0.01B $0.02B 50.00%
1997-12-31 $0.01B $0.01B 56.00%
1997-09-30 $0.01B $0.01B 63.16%
1997-06-30 $0.01B $0.01B 74.07%
1997-03-31 $0.00B $0.01B 61.54%
1996-12-31 $0.00B $0.01B 64.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.334B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00